Feedback / Questions
OCU410ST - Ocugen
https://www.globenewswire.com/news-release/2025/6/16/3099710/0/en/Ocugen-Inc-Announces-U-S-FDA-Clearance-of-Investigational-New-Drug-Amendment-to-Initiate-Phase-2-3-Pivotal-Confirmatory-Clinical-Trial-of-OCU410ST-Modifier-Gene-Therapy-Candidate-f.html
Jun 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next